ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 35 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $28,000 | -33.3% | 78,023 | -7.6% | 0.00% | – |
| Q4 2016 | $42,000 | +20.0% | 84,428 | +23.5% | 0.00% | – |
| Q3 2016 | $35,000 | +40.0% | 68,378 | +226.6% | 0.00% | – |
| Q4 2015 | $25,000 | -79.7% | 20,936 | -62.1% | 0.00% | – |
| Q3 2015 | $123,000 | +7.0% | 55,240 | +11.4% | 0.00% | – |
| Q2 2015 | $115,000 | +202.6% | 49,573 | +181.7% | 0.00% | – |
| Q1 2015 | $38,000 | -87.2% | 17,600 | -86.4% | 0.00% | – |
| Q4 2014 | $297,000 | -56.7% | 129,714 | -49.5% | 0.00% | – |
| Q3 2014 | $686,000 | -63.9% | 256,737 | -49.6% | 0.00% | – |
| Q2 2014 | $1,900,000 | -65.5% | 509,245 | +8.8% | 0.00% | -100.0% |
| Q1 2014 | $5,506,000 | +1186.4% | 468,250 | +813.9% | 0.00% | – |
| Q4 2013 | $428,000 | +197.2% | 51,239 | +230.6% | 0.00% | – |
| Q3 2013 | $144,000 | -11.1% | 15,500 | -6.1% | 0.00% | – |
| Q2 2013 | $162,000 | – | 16,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu KCG Holdings LLC | 86,824 | $31,000 | 0.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 46,100 | $17,000 | 0.00% |
| DEUTSCHE BANK AG\ | 1,405 | $0 | 0.00% |
| CITIGROUP INC | 9,751 | $4,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 17,281 | $6,000 | 0.00% |
| MORGAN STANLEY | 4,250 | $2,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 48,944 | $18,000 | 0.00% |
| BlackRock Inc. | 927,688 | $334,000 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 6,600 | $2,000 | 0.00% |
| Bank of New York Mellon Corp | 62,846 | $22,000 | 0.00% |